HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 14, 12255-12262, April 4, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: 278/14/12255    most recent M203578200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mueller, S. O. Articles by Korach, K. S. Search for Related Content PubMed PubMed Citation Articles by Mueller, S. O. Articles by Korach, K. S. Social Bookmarking                      What's this?

Molecular Determinants of the Stereoselectivity of Agonist Activity of Estrogen Receptors (ER)  and ^*

Stefan O. Mueller^§, Julie M. Hall, Deborah L. Swope, Lars C. Pedersen^¶, and Kenneth S. Korach

From the Laboratories of  Reproductive and Developmental Toxicology and ^¶ Structural Biology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709

The two known estrogen receptors, ER and ER, are hormone-inducible transcription factors that have distinct roles in regulating cell proliferation and differentiation. Previously, our laboratory demonstrated that ER exhibits stereoselective ligand binding and transactivation for several structural derivatives and metabolites of the synthetic estrogen diethylstilbestrol. We have previously described the properties of indenestrol A (IA) enantiomers on ER. In the study presented here, the estrogenic properties of the S and R enantiomers of IA, IA-S and IA-R, respectively, were expanded to examine the activity in different cell and promoter contexts using ER and ER. Using human cell lines stably expressing either ER or ER, we found that IA-S was a more potent activator of transcription than IA-R through ER in human endometrial Ishikawa and breast MDA-MB 231 (MDA) cells. Interestingly, IA-R was more potent on ER when compared with ER in MDA, but not in Ishikawa cells, and IA-R exhibited equally low binding affinities to ER and ER in vitro in contrast to its cell line-dependent preferential activation of ER. Alignment of the protein structures of the ligand-binding domains of ER and ER revealed one mismatched residue, Leu-384 in ER and Met-283 in ER, which may be responsible for making contact with the methyl substituent at the chiral carbon of IA-S and IA-R. Mutagenesis and exchange of this one residue showed that the binding of IA-R and IA-S was not affected by this mutation in ER and ER. However, in transactivation studies, IA-R showed higher potency in activating L384M-mutated ER and wild-type ER compared with wild-type ER and M283L-mutated ER in all cell and promoter contexts examined. Furthermore, IA-R-bound ER L384M and wild-type ER displayed enhanced interactions with the nuclear receptor interaction domains of the coactivators SRC-1 and GRIP1. These data demonstrate that a single residue in the ligand-binding domain determines the stereoselectivity of ER and ER for indenestrol ligands and that IA-R shows cell type selectivity through ER.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. Y. Savinov, A. G. Remacle, V. S. Golubkov, M. Krajewska, S. Kennedy, M. J. Duffy, D. V. Rozanov, S. Krajewski, and A. Y. Strongin Matrix Metalloproteinase 26 Proteolysis of the NH2-Terminal Domain of the Estrogen Receptor {beta} Correlates with the Survival of Breast Cancer Patients. Cancer Res., March 1, 2006; 66(5): 2716 - 2724. [Abstract] [Full Text] [PDF]

				J. Gauduchon, F. Gouilleux, S. Maillard, V. Marsaud, J.-M. Renoir, and B. Sola 4-Hydroxytamoxifen Inhibits Proliferation of Multiple Myeloma Cells In vitro through Down-Regulation of c-Myc, Up-Regulation of p27Kip1, and Modulation of Bcl-2 Family Members Clin. Cancer Res., March 15, 2005; 11(6): 2345 - 2354. [Abstract] [Full Text] [PDF]

				S. O. Mueller, S. Simon, K. Chae, M. Metzler, and K. S. Korach Phytoestrogens and Their Human Metabolites Show Distinct Agonistic and Antagonistic Properties on Estrogen Receptor {alpha} (ER{alpha}) and ER{beta} in Human Cells Toxicol. Sci., July 1, 2004; 80(1): 14 - 25. [Abstract] [Full Text] [PDF]